Creatine kinase system in failing and nonfailing human myocardium

Circulation

Volumn 94, Issue 8, 1996, Pages 1894-1901

  Nascimben, Luigino ^a,b   Ingwall, Joanne S ^a   Pauletto, Paolo ^a,b   Friedrich, Jan ^a   Gwathmey, Judith K ^c,d   Saks, Valdur ^e   Pessina, Achille Cesare ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

cardiomyopathy; creatine; creatine kinase; heart failure; transplantation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE;

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART ATRIUM SEPTUM DEFECT; HEART DILATATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MITRAL VALVE STENOSIS; OPEN HEART SURGERY; PRIORITY JOURNAL;

EID: 0029800446     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.8.1894     Document Type: Article

References (35)

1. Katz AM. Energetics and the failing heart. Hosp Pract. 1991;26:78-90.
2. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation. 1993;87(suppl VII):VII-58-VII-62.
3. Khuchua ZA, Ventura-Clapier R, Kuznetsov AV, Grishin MN, Saks VA. Alterations in the creatine kinase system in the myocardium of cardiomyopathic hamsters. Biochem Biophys Res Commun. 1989;165:748-757.
4. Neubauer S, Horn M, Naumann A, Tian R, Hu K, Laser M, Friedrich J, Gaudron P, Schnackerz K, Ingwall JS, Ertl G. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest. 1995;95:1092-1100.
5. Nascimben L, Friedrich J, Liao R, Pauletto P, Pessina AC, Ingwall JS. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation. 1995;91:1824-1833.
6. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy. Circ Res. 1996;78:893-902.
7. Tian R, Nascimben L, Daouk R, Ingwall JS. Depletion of energy reserve via creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol. 1996;28:755-765.
8. Zweier JL, Jacobus WE, Korecky B, Brandejs-Barry Y. Bioenergetic consequences of cardiac phosphocreatine depletion induced by creatine analogue feeding. J Biol Chem. 1991;266:20296-20304.
9. Hamman BL, Bittl JA, Jacobus WE, Allen PD, Spencer RS, Tian R, Ingwall JS. Inhibition of the creatine kinase reaction decreases the contractile reserve of the isolated rat heart. Am J Physiol. 1995;269:H1030-H1036.
10. van Deursen J, Heerschap A, Oerlemans F, Ruitenbeek W, Jap P, ter Laak H, Wieringa B. Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell. 1993;74:621-631.
11. Nascimben L, Pauletto P, Pessina AC, Reis I, Ingwall JS. Decreased energy reserve may cause pump failure in human dilated cardiomyopathy. Circulation. 1991;84(suppl II):II-563. Abstract.
12. Sylven C, Lin L, Jansson E, Sotonyi P, Fu LX, Waagstein F, Hjalmarsson A, Marcus C, Bronnegard M. Ventricular adenine nucleotide translocator mRNA is upregulated in dilated cardiomyopathy. Cardiovasc Res. 1993;27:1295-1299.
13. Bristow MR, Anderson FL, Port JD, Skerl L, Hershberger RE, Larrabee P, O'Connell JB, Renlund DG, Volkman K, Murray J, Feldman AM. Differences in β-adrenergic neuroeffector mechanism in ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991;84:1024-1039.
14. 31P magnetic resonance spectroscopy. Lancet. 1991;338:973-976.
15. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J. 1991;122:795-801.
16. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 1992;86:1810-1818.
17. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W, Allen PD. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 1985;313:1050-1054.
18. Basson CT, Grace AM, Roberts R. Enzyme kinetics of a highly purified mitochondrial creatine kinase in comparison with cytosolic forms. Mol Cell Biochem. 1985;67:151-159.
19. Morrison JF, Cleland WW. Isotope exchange studies of the mechanism of the reaction catalyzed by adenosine triphosphate: creatine phosphotransferase. J Biol Chem. 1966;241:673-683.
20. 31P NMR surface coil studies in brain, heart and skeletal muscle of the living rat. Biochemistry. 1987;26:6083-6090.
21. Polimeni PI. Measurement of myocardial electrolyte distributions. Tech Life Cardiovasc Physiol. 1984;317:1-34.
22. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G. Regional myocardial metabolism of high energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med. 1990;323:1593-1600.
23. Regitz V, Fleck E. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol. 1992;69:1574-1580.
24. Bashore TM, Magorien DJ, Letterio J, Shaffer P, Unverferth DV. Histologic and biochemical correlates of left ventricular chamber dynamics in man. J Am Coll Cardiol. 1987;9:734-742.
25. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992;85:790-804.
26. Waldenstrom A, Martinussen HJ, Kock J, Ronquist G, Hultman J. Parasympathetic muscarinic stimulation limits noradrenaline induced myocardial creatine kinase release: a study in the isolated perfused working rat heart. Scand J Clin Lab Invest. 1994;54:615-621.
27. Chapados RA, Gruver EJ, Ingwall JS, Marsh JD, Gwathmey JK. Chronic administration of cardiovascular drugs: altered energetics and transmembrane signaling. Am J Physiol. 1992;263:H1576-H1586.
28. Conn JN, Levine B, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
29. Anderson PAW, Malouf NN, Oakeley AE, Pagani ED, Allen PD. Troponin T isoform expression in humans: a comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ Res. 1991;69:1226-1233.
30. Younes A, Schneider JM, Bercovici J, Swynghedauw B. Redistribution of creatine kinase isoenzymes in chronically overloaded myocardium. Cardiovasc Res. 1984;19:15-19.
31. Sylven C, Lin L, Kallner A, Sotonyi E, Somogy E, Jansson E. Dynamics of creatine kinase shuttle enzymes in the human heart. Eur J Clin Invest. 1991;21:350-354.
32. van der Laarse A, Hollaar L, Kok SW, van den Eijnde S, Souverijn JHM, Hoedemaeker PJ, Bruschke AVG, Myocardial creatine kinase-MB concentration in normal and explanted human hearts and released from hearts of patients with acute myocardial infarction. Clin Physiol Biochem, 1992;9:11-17.
33. Metha HB, Popovich BK, Dillman WK. Ischemia induces changes in the level of mRNAs coding for stress protein 71 and creatine kinase M. Circ Res. 1988;63:512-517.
34. Sharkey SW, Elsperger LM, Markami M, Apple FS. Canine myocardial creatine kinase isoenzyme response to coronary artery occlusion. Am J Physiol. 1989;256:H508-H514.
35. Reiss N, Kaye AM. Identification of the major component of the estrogen-induced protein of rat uterus as the BB isozyme of creatine kinase. J Biol Chem. 1981;256:5741-5749.